{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:41:55Z","timestamp":1759412515422},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T00:00:00Z","timestamp":1377302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl."],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00103-013-1792-4","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T06:42:08Z","timestamp":1377758528000},"page":"1253-1259","source":"Crossref","is-referenced-by-count":6,"title":["Sicherheit und Vertr\u00e4glichkeit von monovalenten Masern- und kombinierten Masern-, Mumps-, R\u00f6teln- und Varizellenimpfstoffen"],"prefix":"10.1007","volume":"56","author":[{"given":"D.","family":"Mentzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Keller-Stanislawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,24]]},"reference":[{"key":"1792_CR1","doi-asserted-by":"crossref","unstructured":"Strebel PM (2013) Measles vaccine. In: Plotkin SA, Orenstein WA, Offit PA (Hrsg) Vaccines. Elsevier Saunders, S\u00a0352\u00a0ff","DOI":"10.1016\/B978-1-4557-0090-5.00028-8"},{"key":"1792_CR2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/INF.0b013e318060aca1","volume":"26","author":"Wichmann","year":"2007","unstructured":"Wichmann O, Hellenbrand W, Sagebiel D et al (2007) Large measles outbreak at a German public school 2006. Pediatr Infect Dis J 26(9):782\u2013786","journal-title":"Pediatr Infect Dis J"},{"key":"1792_CR3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/INF.0b013e3181a3e2d5","volume":"28","author":"Hahn\u00e9","year":"2009","unstructured":"Hahn\u00e9 S, Macey J, Binnendijk R van et al (2009) Rubella outbreak in the Netherlands, 2004\u20132005: high burden of congenital infection and spread to Canada. Pediatr Infect Dis J 28(9):795\u2013800","journal-title":"Pediatr Infect Dis J"},{"key":"1792_CR4","unstructured":"WHO Aide memoire. Adverse events following immunization (AEFI): causality assessment. http:\/\/whqlibdoc.who.int\/aide-memoire\/a87773_eng.pdf"},{"key":"1792_CR5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10(6):483\u2013486","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1792_CR6","unstructured":"Mentzer D, Keller-Stanislawski B (2012) Daten zur Pharmakovigilanz von Impfstoffen aus dem Jahr 2009. Epidemiol Bull 19"},{"key":"1792_CR7","unstructured":"Keller-Stanislawski B, Streit R, Paeschke N (2012) Signaldetektion und -analyse, Bulletin zur Arzneimittelsicherheit IV. http:\/\/www.pei.de\/SharedDocs\/Downloads\/vigilanz\/bulletin-zur-arzneimittelsicherheit\/2012\/4\u20132012.pdf?__blob=publicationFile&v=9"},{"key":"1792_CR8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.hco.0000221576.33501.83","volume":"21","author":"Tester","year":"2006","unstructured":"Tester DJ, Ackermann MJ (2006) The role of molecular autopsy in unexplained cardiac death. Curr Opin Cardiol 21:166\u00a0ff","journal-title":"Curr Opin Cardiol"},{"key":"1792_CR9","doi-asserted-by":"crossref","unstructured":"Granmaison GL de la (2006) Is there progress in the autopsy diagnosis of sudden unexpected death in adults? Forensic Sci Int 156(2\u20133):138\u00a0ff","DOI":"10.1016\/j.forsciint.2004.12.024"},{"key":"1792_CR10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/qjmed\/hcg038","volume":"96","author":"Bowker","year":"2003","unstructured":"Bowker TJ, Wood DA, Davies MJ et al (2003) Sudden, unexpected cardiac or unexplained death in England: a national survey. QJM 96:269","journal-title":"QJM"},{"key":"1792_CR11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/adc.57.8.572","volume":"57","author":"Molander","year":"1982","unstructured":"Molander N (1982) Sudden natural death in later childhood and adolescents. Arch Dis Child 57:572\u00a0ff","journal-title":"Arch Dis Child"},{"key":"1792_CR12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/adc.82.6.456","volume":"82","author":"Morentin","year":"2000","unstructured":"Morentin B, Aguilera B, Garamendi PM, Suarez-Mier MP (2000) Sudden unexpected non-violent death between 1 and 19 years in north Spain. Arch dis Child 82:456\u00a0ff","journal-title":"Arch dis Child"},{"key":"1792_CR13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/bmj.305.6853.538","volume":"305","author":"Davies","year":"1992","unstructured":"Davies MJ (1992) Unexplained death in fit young people. BMJ 305:538\u2013539","journal-title":"BMJ"},{"key":"1792_CR14","first-page":"41","volume":"106","author":"Kauferstein","year":"2009","unstructured":"Kauferstein S, Kiehne N, Neumann T et al (2009) Cardiac gene defects can cause sudden cardiac death in young. Dtsch Arztebl Int 106:41\u201347","journal-title":"Dtsch Arztebl Int"},{"key":"1792_CR15","first-page":"B4403","volume":"59","author":"Winkel","year":"2012","unstructured":"Winkel BG (2012) Sudden cardiac death in young Danes. Dan Med J 59(2):B4403","journal-title":"Dan Med J"},{"key":"1792_CR16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.2.5.3246","volume":"2","author":"Kuter","year":"2006","unstructured":"Kuter BJ, Brown ML, Hartzel J et al (2006) Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad). Hum Vaccin 2:205\u2013214","journal-title":"Hum Vaccin"},{"key":"1792_CR17","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","volume":"27","author":"Czajka","year":"2009","unstructured":"Czajka H, Schuster V, Zepp F et al (2009) A combined measles, mumps, rubella and varicella vaccine (Priorix-TetraTM): immunogenicity and safety profile. Vaccine 27:6504\u20136511","journal-title":"Vaccine"},{"key":"1792_CR18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa003077","volume":"345","author":"Barlow","year":"2001","unstructured":"Barlow WE, Davis RL, Glasser JW et al (2001) The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 345:656\u2013661","journal-title":"N Engl J Med"},{"key":"1792_CR19","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","volume":"27","author":"Jacobsen","year":"2009","unstructured":"Jacobsen SJ, Ackerson BK, Sy LS et al (2009) Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 27:4656\u20134661","journal-title":"Vaccine"},{"key":"1792_CR20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","volume":"126","author":"Klein","year":"2010","unstructured":"Klein NP, Fireman B, Yih WK et al (2010) Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 126:e1\u2013e8","journal-title":"Pediatrics"},{"key":"1792_CR21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.292.3.351","volume":"292","author":"Vestergaard","year":"2004","unstructured":"Vestergaard M, Hviid A, Madsen KM et al (2004) MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. JAMA 292(3):351\u2013357","journal-title":"JAMA"},{"key":"1792_CR22","unstructured":"Institute of Medicine: measles and mumps vaccines. In: Stratton KR, Howe CJ, Johnston RB Jr (Hrsg) (1994) Adverse events associated with childhood vaccines. National Academy Press, Washington DC, S\u00a0163\u2013169"},{"key":"1792_CR23","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1542\/peds.2007-1578","volume":"121","author":"France","year":"2008","unstructured":"France EK, Glanz J, Xu S et al (2008) Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 121:e687\u2013e692","journal-title":"Pediatrics"},{"key":"1792_CR24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.10.015","volume":"156","author":"Mantadakis","year":"2010","unstructured":"Mantadakis E, Farmaki E, Buchanan GR (2010) Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management. J Pediatr 156:623\u2013628","journal-title":"J Pediatr"},{"key":"1792_CR25","first-page":"27","volume":"24","author":"D","year":"2000","unstructured":"D\u2019Souza R, Campbell-Lloyd S, Isaacs D et al (2000) Adverse events following immunisation associated with the 1998 Australian measles control campaign. Commun Dis Intell 24:27\u201333","journal-title":"Commun Dis Intell"},{"key":"1792_CR26","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bmj.323.7317.869a","volume":"323","author":"Carapetis","year":"2001","unstructured":"Carapetis JR, Curtis N, Royle J (2001) MMR immunisation: true anaphylaxis to MMR vaccine is extremely rare. BMJ 323:869","journal-title":"BMJ"},{"key":"1792_CR27","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1542\/peds.110.6.e71","volume":"110","author":"Pool","year":"2002","unstructured":"Pool V, Braun MM, Kelso JM et al (2002) Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps-rubella vaccine in the United States. Pediatrics 110:e71","journal-title":"Pediatrics"},{"key":"1792_CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/bmj.309.6949.223","volume":"309","author":"Aickin","year":"1994","unstructured":"Aickin R, Hill D, Kemp A (1994) Measles immunisation in children with allergy to egg. BMJ 309:223\u2013225","journal-title":"BMJ"},{"key":"1792_CR29","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0091-6749(97)70038-1","volume":"99","author":"Masahiro","year":"1997","unstructured":"Masahiro S, Takami Y, Takahiro A et al (1997) Development of IgE antibody to gelatin in children with systemic immediate-type reactions to vaccines. J Allergy Clin Immunol 99:720\u2013721","journal-title":"J Allergy Clin Immunol"},{"key":"1792_CR30","doi-asserted-by":"crossref","unstructured":"Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C (2012) Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2","DOI":"10.1002\/14651858.CD004407.pub3"},{"key":"1792_CR31","unstructured":"Centers for Disease Control (CDC) (1989) Adverse events following immunization surveillance report No. 3: 1985\u20131986"},{"key":"1792_CR32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1542\/peds.110.5.957","volume":"110","author":"M\u00e4kel\u00e4","year":"2002","unstructured":"M\u00e4kel\u00e4 A, Nuorti JP, Peltola H (2002) Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 110:957\u2013963","journal-title":"Pediatrics"},{"key":"1792_CR33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/01.inf.0000234067.84848.e1","volume":"25","author":"Ray","year":"2006","unstructured":"Ray P, Hayward J, Michelson D et al (2006) Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J 25:768\u2013773","journal-title":"Pediatr Infect Dis J"},{"key":"1792_CR34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13550280290100752","volume":"8","author":"Jin","year":"2002","unstructured":"Jin L, Beard S, Hunjan R et al (2002) Characterization of measles virus strains causing SSPE: a study of 11 cases. J Neurovirol 8:335\u2013344","journal-title":"J Neurovirol"},{"key":"1792_CR35","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/497169","volume":"192","author":"Bellini","year":"2005","unstructured":"Bellini WJ, Rota JS, Lowe LE et al (2005) Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 192:1686\u20131693","journal-title":"J Infect Dis"},{"key":"1792_CR36","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/ije\/dym207","volume":"36","author":"Campbell","year":"2007","unstructured":"Campbell H, Andrews N, Brown KE et al (2007) Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 36:1334\u20131348","journal-title":"Int J Epidemiol"},{"key":"1792_CR37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/520449","volume":"29","author":"Bitnun","year":"1999","unstructured":"Bitnun A, Shannon P, Durward A et al (1999) Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis 29:855\u2013861","journal-title":"Clin Infect Dis"},{"key":"1792_CR38","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00006454-200012000-00002","volume":"19","author":"Patja","year":"2000","unstructured":"Patja A, Davidkin I, Kurki T et al (2000) Serious adverse events after measles-mumps-rubella vaccination during fourteen-year prospective follow-up. Pediatr Infect Dis J 19(12):1127\u20131134","journal-title":"Pediatr Infect Dis J"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1792-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-013-1792-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1792-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1792-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T11:35:02Z","timestamp":1563795302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-013-1792-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,24]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["1792"],"URL":"https:\/\/doi.org\/10.1007\/s00103-013-1792-4","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,24]]}}}